29 May 2001, 10:35 UTC
GA Accomplishments - Valuation Methodology - and other issues
- From
- Amr Ibrahim amr.ibrahim@enron.com
- To
-
Nicholas O'Day, takashi.kimura@enron.com, Mark Crowther, Michael Grimes, Mika Watanabe, Llewelyn Hughes, tom.fitzgibbon@enron.com, makiko.imai@enron.com, James D Steffes, Rebecca W Cantrell, Dave Mangskau, Ron McNamara
and 101 more
Christi L Nicolay, Dave Perrino, mike.roan@enron.com, Susan M Scott, Thane Twiggs, Steve Walton, Charles Yeung, Jennifer Thome, Linda J Noske, Joan Stransky, Paul Hennemeyer, Peter Styles, Bruno Gaillard, teun.biert@enron.com, Nailia Dindarova, Antoine Duvauchelle, Jan Haizmann, Xi Xi, Philip Davies, viviana.florio@enron.com, Amber Keenan, Doug Wood, Paul Dawson, Brendan Devlin, justyna.ozegalska@enron.com, Merle Glen, Nick Elms, Alfredo Huertas, alisha.nathoo@enron.com, Kerryann Irwin, Aleck Dadson, Robert Hemstock, Paul Kaufman, Janine Migden, Steve Montovano, Alan Comnes, Jeff Dasovich, Susan J Mara, Sandra McCubbin, Lysa Akin, Roy Boston, Barbara A Hueter, Susan M Landwehr, Donald Lassere, Bill Moore, Kerry Stroup, Daniel Allegretti, Tom Chapman, Howard Fromer, Tom Hoatson, Frank Rishe, Marchris Robinson, Dan Staines, Kathleen Sullivan, Chauncey Hood, Jean Ryall, joe.allen@enron.com, Jose Bestard, Sergio Assad, Guillermo Canovas, Luiz Maurer, jose.reis@enron.com, Mike D Smith, fred.sampaio@enron.com, gisele.braz@enron.com, Linda Robertson, ramon.alvarez@enron.com, Tom Briggs, Stephen D Burns, Donna Fulton, John Hardy, christopher.long@enron.com, Allison Navin, Sarah Novosel, John Shelk, Carin Nersesian, Lora Sullivan, Carolyn Cooney, Larry Decker, Sue Nord, Stacey Bolton, Lara Leibman, John Neslage, Eric Benson, Mona L Petrochko, Carmen Perez, Lisa Yoho, Maria Arefieva, Margaret Huson, Alberto Levy, Janel Guerrero, Harry Kingerski, Patrick Keene, Stella Chan, Gloria Ogenyi, Vinio Floris, Robert Frank, Robert Neustaedter, Leslie Lawner, Nancy Hetrick, Doug Schuler - Bcc
- Richard Shapiro
- Date
- Tue, 29 May 2001 03:35:00 -0700 (PDT)
Colleagues: I hope that a short note on methodology on accomplishments' valuation will be of help to all of us at this stage. Up to this moment, the current criteria is still the same established by Jim, John, and Gia Team in the last two years. Its purpose was, and still, is to ensure that Public Affairs continues to generate more value than actual expense. The process, hopefully, should drive GA staff to view themselves as "originators" creating bottom-line value through (as an example): revenue enhancement (new opportunity, market expansion) cost reduction (e.g., fee delay, rate decrease). The value calculation process focused on the following rules (called SCORE): Simplicity Consistency Objectivity Reasonableness Equity Perhaps it is helpful to list some of the methodologies submitted so far. With no specific preference, they are: A percentage of Enron's business on a specific hub, or transmission connection (the percentage is subjectively determined) Impact of a specific deal on Enron's stock price (in total or part, again, subjectively determined) The result of what-if analysis to estimate the would be cost had the legislation passed (or did not pass), or a settlement reached (or not reached) The amount of financing needs that was secured for a deal NPV of a project. An extension would be the size of market identified or deals originated. The market size that Enron is targeting. Value at risk in a specific project or activity The methodology adopted by the relevant regulatory regimen to calculated specific cost item that have been deferred, reduced, or avoided. An extension would be the impact of tariffs determination after intervention (in part or total). The buy/sell spread of a portion of the market size that was released after intervention. I shall keep you posted with any change--in any case, it shall not happen without full consultation with you--meanwhile, please let me know if you have any question in this regard. Brgrds AI 713-853-3037